Co-Diagnostics Receives Grant of Australian Patent Covering Co-Dx PCR Platform Technologies
The Australian patent represents the first patent granted for the Company’s new point-of-care testing platform. […]
The Australian patent represents the first patent granted for the Company’s new point-of-care testing platform. […]
Merit Medical’s Fred Lampropoulos Honored by Nasdaq […]
Perimeter Solutions Announces Agreement to Acquire MMT for $685 Million […]
Freyya Recognized at Transatlantic Angel Competition (TAAC8) […]
Co-Diagnostics Joint Venture, CoSara, Invited to Participate in 2nd Advanced TB Diagnostics Course in Chennai, India […]
Collaboration expands Owlet’s national DME footprint, strengthens access for Medicaid and TRICARE families, and supports continued growth in prescription-backed revenue channel. […]
In-vitro studies confirmed strong uptake of cell-targeting nanoparticles by cancer cells and strong activation of Smart mRNAs inside cancer cells […]
Peel Therapeutics CEO Joshua Schiffman Presents at CureCRC Summit […]
Ratio Therapeutics has Successfully Dosed the First Cohort in its Phase 1/2 Study Evaluating a Novel FAP-Targeted Radiopharmaceutical in Patients with Late-Stage Aggressive Sarcomas […]
Investors Buy up Stocks in Biggest Follow-on Offering Day in Biotech History […]
Talent Ready Utah Calling for Innovator Input […]
TGA approval enables regional launch of Owlet’s clinically validated, award-winning infant health monitor; Owlet360™ subscription marks first international expansion of the Company’s recurring-revenue platform. […]